New Treatment Boosts Survival in Kids with Neuroblastoma
Cancer is the leading cause of death by disease for children in the United States. Tragically, children with the rare cancer neuroblastoma often succumb to the disease despite aggressive treatment. That is until exciting new research showed that adding an experimental antibody to treatment shows promise to save the lives of children with this…...
Catching Cancer Cells on Their Way to Spreading
NEW NFCR-Supported Technology is Ready for Clinical Use With a better understanding of the genetic changes in cancer cells, and a more effective way to capture them, oncologists and scientists can be alerted to drug resistance and metastasis —allowing them to more quickly select new drugs or better therapies for…...
Strategic Media Partner
